Zota Health Care Ltd. Issues Corrigendum for FY26 Consolidated Cash Flow Statement
Zota Health Care Limited issued a corrigendum for its FY26 Consolidated Cash Flow Statement due to typographical errors. This correction does not impact other financial statements. The rectified figures are available on the company and NSE websites.
This is a routine correction of a past filing and does not alter the company's overall financial performance or future outlook.
The announcement is a correction of a previous filing and does not introduce new financial performance information or significant business changes.
Zota Health Care Limited has issued a corrigendum to its Consolidated Cash Flow Statement for the financial year ended March 31, 2026. This announcement follows up on the Audited Financial Results for the quarter and year ended March 31, 2026, which were submitted on May 22, 2026.
The company identified inadvertent typographical errors in the Consolidated Cash Flow Statement after its initial submission. The enclosed corrigendum (Annexure-1) rectifies these specific figures. It is intended to be read in conjunction with the previously submitted Audited Financial Results.
This corrigendum is limited to the figures within the Consolidated Cash Flow Statement for the year ended March 31, 2026. It does not affect the Standalone and Consolidated Statement of Assets and Liabilities, the Audited Standalone & Consolidated Financial Results for the quarter and year ended March 31, 2026, or the Standalone Cash Flow Statement for the same period.
The corrected Consolidated Cash Flow Statement for the year ended March 31, 2026, is available on the company's website (www.zotahealthcare.com) and the National Stock Exchange of India Limited's website (www.nseindia.com). The figures provided in lakhs show changes in 'Interest Income', 'Operating Profit before Working Capital Changes', 'Cash Generated from Operations', 'Net Cash Flow from/ (Used in) Operating Activities', 'Acquisition of property, plant and equipment, capital work-in progress and intangible assets', 'Interest Received', 'Net Cash Flow (Used in) Investing Activities', 'Principal payment of lease liability', and 'Net Cash Flow from / (Used in) Financing Activities'.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.